Timothy Schmid sold $9.2M of JNJ
EVP, WW Chair, MedTech at JOHNSON & JOHNSON. 33,597 shares at an average of $274.74, traded Sep 2, 2026, filed Sep 4, 2026.
Score components
- +20RoleChair
- +25Trade size$9.2M at market
- +20Share of holdings soldSold 92% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000200406-26-000179, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | MOption exercise Common Stock | +11,070 | $131.94 | $1.5M | 36,517 | 38 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stock | -11,070 | $274.74 | $3.0M | 25,447 | 38 d ago |
| Sep 2, 2026 | MOption exercise Common Stock | +22,527 | $151.41 | $3.4M | 47,974 | 38 d ago |
| Sep 2, 2026 | SOpen-market sale Common Stock | -22,527 | $274.74 | $6.2M | 25,447 | 38 d ago |
| Sep 2, 2026 | MOption exercise Employee Stock Options (Right to Buy)derivative | -11,070 | $0.00 | $0 | 0 | 38 d ago |
| Sep 2, 2026 | MOption exercise Employee Stock Options (Right to Buy)derivative | -22,527 | $0.00 | $0 | 0 | 38 d ago |
Related signals
Other insiders at JOHNSON & JOHNSON and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | JOHNSON & JOHNSON | Robert J Decker VP Corporate Controller | $1.2M 6,999 shares | -25% | |
| 28Weak | JOHNSON & JOHNSON | Timothy Schmid EVP, WW Chair, MedTech | $63k 403 shares | -3% | |
| 60Notable | JOHNSON & JOHNSON | Joseph J Wolk Exec VP, CFO | $2.0M 13,015 shares | -100% | |
| 34Weak | JNJbuy JOHNSON & JOHNSON | Mark A Weinberger director | $147k 1,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.